The hTERT test is an immunocytochemistry (ICC) assay registered for the detection of human telomerase reverse transcriptase (hTERT) in cytopathology samples. It is used as an adjunct to urine cytology to help resolve indeterminate cytology results and identify patients with increased risk of bladder cancer.

The product, anti-hTERT antibody (SCD-A7), is:

  • An antibody targeted against the hTERT, the protein component of the telomerase complex.
  • Listed with the FDA as a Class I medical device in the USA, with existing reimbursement in that market.
  • Anti-hTERT Antibody (SCD-A7) Part Number 01-5002 (SDS).

hTERT ICC Test flyer